Florian Deisenhammer
Florian Deisenhammer publishes mostly in Pathology and Forensic Medicine, Neurology and Rheumatology, on topics such as Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders and Polyomavirus and related diseases.
- World rank
- #387,673 of 7,710,434 ranked researchers
- Rank in Austria
- #2,617 of 43,330
- Works
- 376
- Citations
- 14k
- Citations per work
- 37.4
What does Florian Deisenhammer research?
Florian Deisenhammer's work is mostly in Medicine (59%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences22259.1%
- Medicine22259.1%
- Everything else12834.1%
- Life Sciences266.8%
- 1Pathology and Forensic Medicine23% of their works
- 2Neurology18% of their works
- 3Rheumatology7% of their works
- 4Immunology7% of their works
- 5Oncology6% of their works
- 6Radiology, Nuclear Medicine and Imaging5% of their works
Research topics
- Multiple Sclerosis Research Studies
- Peripheral Neuropathies and Disorders
- Polyomavirus and related diseases
- Systemic Lupus Erythematosus Research
- Monoclonal and Polyclonal Antibodies Research
- Cerebrospinal fluid and hydrocephalus
- Autoimmune Neurological Disorders and Treatments
- Immunotherapy and Immune Responses
Which keywords describe Florian Deisenhammer's research?
The keywords of their largest research topics: Cognitive Impairment, Diagnostic Criteria, Multiple Sclerosis, Neuromyelitis Optica, Neurological Disorders, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Guillain-Barré Syndrome and Autoantibodies.
- Immunity
- Paraneoplastic Syndromes
- Cerebrospinal Fluid
- Therapeutic Antibodies
- Systemic Lupus Erythematosus
- Merkel Cell Carcinoma
- Autoantibodies
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Neuromyelitis Optica
- Diagnostic Criteria
- Cognitive Impairment
- Multiple Sclerosis
- Neurological Disorders
- Guillain-Barré Syndrome
- Antiphospholipid Syndrome
- Polyomavirus
- Fc Receptors
- Anti-NMDA Receptor Encephalitis
- Glymphatic System
- Dendritic Cells
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Cognitive Impairment2412 topics
- Diagnostic Criteria2412 topics
- Multiple Sclerosis2191 topic
- Neuromyelitis Optica2191 topic
- Neurological Disorders1473 topics
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy1031 topic
- Guillain-Barré Syndrome1031 topic
- Autoantibodies682 topics
- Antiphospholipid Syndrome461 topic
- Merkel Cell Carcinoma461 topic
- Polyomavirus461 topic
- Systemic Lupus Erythematosus461 topic
- Fc Receptors381 topic
- Therapeutic Antibodies381 topic
- Anti-NMDA Receptor Encephalitis221 topic
- Cerebrospinal Fluid221 topic
- Glymphatic System221 topic
- Paraneoplastic Syndromes221 topic
- Dendritic Cells191 topic
- Immunity191 topic
Where does Florian Deisenhammer work?
Florian Deisenhammer's main affiliation in the publication record is Innsbruck Medical University, Austria.
How many publications and citations does Florian Deisenhammer have?
OpenAlex counts 376 works and 14,051 citations for Florian Deisenhammer, an h-index of 60, ranking #387,673 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Florian Deisenhammer. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.